On Monday, Tango Therapeutics Inc (NASDAQ: TNGX) was 3.08% up from the session before settling in for the closing price of $7.47. A 52-week range for TNGX has been $5.15 – $13.03.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 132.62%. When this article was written, the company’s average yearly earnings per share was at -22.90%. With a float of $57.71 million, this company’s outstanding shares have now reached $102.20 million.
Considering the fact that the conglomerate employs 140 people, you should pay attention to its efficiency factor.
Tango Therapeutics Inc (TNGX) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Tango Therapeutics Inc stocks. The insider ownership of Tango Therapeutics Inc is 46.14%, while institutional ownership is 56.76%. The most recent insider transaction that took place on Sep 13 ’24, was worth 709,756. In this transaction 10% Owner of this company sold 67,400 shares at a rate of $10.53, taking the stock ownership to the 16,859,075 shares. Before that another transaction happened on Sep 13 ’24, when Company’s Affiliate proposed sale 67,400 for $10.50, making the entire transaction worth $707,700.
Tango Therapeutics Inc (TNGX) Recent Fiscal highlights
#####
According to the Wall Street analysts, stocks earnings will be around -22.90% per share during the next fiscal year.
Tango Therapeutics Inc (NASDAQ: TNGX) Trading Performance Indicators
You can see what Tango Therapeutics Inc (TNGX) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 7.49. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 19.41.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.13, a number that is poised to hit -0.37 in the next quarter and is forecasted to reach -1.46 in one year’s time.
Technical Analysis of Tango Therapeutics Inc (TNGX)
Compared to the last year’s volume of 0.75 million, its volume of 0.89 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 13.53%. Additionally, its Average True Range was 0.76.
During the past 100 days, Tango Therapeutics Inc’s (TNGX) raw stochastic average was set at 22.32%, which indicates a significant increase from 13.71% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 79.31% in the past 14 days, which was higher than the 75.32% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $9.61, while its 200-day Moving Average is $9.37. Nevertheless, the first resistance level for the watch stands at $7.85 in the near term. At $7.99, the stock is likely to face the second major resistance level. The third major resistance level sits at $8.21. If the price goes on to break the first support level at $7.49, it is likely to go to the next support level at $7.27. Now, if the price goes above the second support level, the third support stands at $7.13.
Tango Therapeutics Inc (NASDAQ: TNGX) Key Stats
There are 106,846K outstanding shares of the company, which has a market capitalization of 824.98 million. As of now, sales total 36,530 K while income totals -101,740 K. Its latest quarter income was 19,880 K while its last quarter net income were -25,550 K.
